Literature DB >> 12458121

Evaluation of the BDProbeTec ET DTB assay(1) for direct detection of Mycobacterium tuberculosis complex from clinical samples.

J Maugein1, J Fourche, S Vacher, C Grimond, C Bebear.   

Abstract

The purpose of this study was to evaluate the ability of BDProbeTec ET DTB system to detect Mycobacterium tuberculosis complex directly from clinical specimens. A total of 628 specimens (553 respiratory and 75 non respiratory specimens) were collected from 478 patients. These samples were tested with the BDProbeTec ET DTB assay and results were compared with acid fast microscopy and culture. Sixty eight out of 77 culture positive M. tuberculosis complex samples were detected with overall sensitivity and specificity of 89.5% and 98.2% respectively. Overall sensitivity was 100% in smear positive samples and 79% in smear negative samples. After resolution of discrepant results, sensitivity and specificity for respiratory samples were 91.6% and 98.7% respectively. BDProbeTec ET DTB assay demonstrated to be a rapid, sensitive and specific method for detection of M. tuberculosis complex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458121     DOI: 10.1016/s0732-8893(02)00427-3

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  8 in total

Review 1.  Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples.

Authors:  Claudio Piersimoni; Claudio Scarparo
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 2.  Molecular diagnostics in tuberculosis.

Authors:  V C C Cheng; W W Yew; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

Review 3.  Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis.

Authors:  S Greco; E Girardi; A Navarra; C Saltini
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

4.  Use of a disposable water filter for prevention of false-positive results due to nontuberculosis mycobacteria in a clinical laboratory performing routine acid-fast staining for tuberculosis.

Authors:  Hui-Zin Tu; Chiao-Shan Chen; Tsi-Shu Huang; Wen-Kuei Huang; Yao-Shen Chen; Yung-Ching Liu; Yusen Eason Lin
Journal:  Appl Environ Microbiol       Date:  2007-08-03       Impact factor: 4.792

5.  Performance assessment of the CapitalBio mycobacterium identification array system for identification of mycobacteria.

Authors:  Jingbo Liu; Jun Yue; Zihe Yan; Min Han; Zhijun Han; Lingjie Jin; Yanlin Zhao
Journal:  J Clin Microbiol       Date:  2011-11-16       Impact factor: 5.948

6.  Performance assessment of a nested-PCR assay (the RAPID BAP-MTB) and the BD ProbeTec ET system for detection of Mycobacterium tuberculosis in clinical specimens.

Authors:  Jann-Yuan Wang; Li-Na Lee; Chin-Sheng Chou; Chung-Yi Huang; Shu-Kuan Wang; Hsin-Chih Lai; Po-Ren Hsueh; Kwen-Tay Luh
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

7.  Performance assessment of the DR. MTBC Screen assay and the BD ProbeTec ET system for direct detection of Mycobacterium tuberculosis in respiratory specimens.

Authors:  Jann-Yuan Wang; Li-Na Lee; Hsiao-Leng Hsu; Po-Ren Hsueh; Kwen-Tay Luh
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

8.  Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression.

Authors:  Daphne I Ling; Laura L Flores; Lee W Riley; Madhukar Pai
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.